GSK’s chief scientific officer, Hal Barron, is jumping ship, dealing a blow to the drugmaker as it seeks to rebuild its pipeline of new medicines and gears up for a corporate split in the summer. LEARN MORE: ow.ly/MJMj50HyWx9 aspenalert.com #biotechnews
0
0
3
0
0
Download Image